Defining optimal glucose targets in critically ill patients with pre-existing type 2 diabetes and chronic hyperglycaemia.
Not Applicable
Completed
- Conditions
- Critically ill patients type 2 diabetes and chronic hyperglycaemiaMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12612001274864
- Lead Sponsor
- Dr Adam Deane
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 83
Inclusion Criteria
New admission to ICU
HbA1c greater than 6.9% or 51 mmol/mol
Anticipated to remain in ICU for 48 hours or greater
Exclusion Criteria
HbA1c less than 6.9%
Type-1 diabetes.
Expected to die within 48 hours
Not expected to stay for at least 48 hours
Readmission to IC
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All-cause mortality (ICU, hospital and 90 day) will be assessed from medical records.[Within 90 days of current ICU admission.]
- Secondary Outcome Measures
Name Time Method